UnknownNot Applicable

Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms

Israel460 participantsStarted 2022-04-14

Plain-language summary

This study will recruit 460 participants who self-report high symptoms of anxiety. Participants will be randomly assigned to one of 4 groups: one analog intervention of Imagery Rescripting (IR) for memories, an analog intervention of IR for future events, and analog intervention of Imaginal Exposure (IE) for memories and an analog intervention of IE for future events. We will examine the efficacy and mechanisms behind each intervention.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: We will recruit participants based on attainment of SPIN score \>= 24 and/or ASI-3 scores \>=23 and/or OCI-R subscale scores (not including hoarding subscale) \>=6 and/or GAD-7 scores \>= 9 . Exclusion Criteria: Diagnosis of psychosis, active suicidality, post-traumatic stress disorder, acute stress disorder. Can't report a negative imagery related to a future social scenario. Attending active psychotherapy sessions. Started/stopped taking psychotherapeutic medications in the last 3 months.

What they're measuring

Change from baseline in the Social phobia inventory (SPIN)

Timeframe: Will be measured at Baseline (7 or 14 days before the intervention), Intervention (immediately after the intervention), post-intervention ( 7 days after the intervention) and Follow-up (28 days after the intervention)

Change from baseline in the Anxiety Sensitivity Index - 3 (ASI-3)

Timeframe: Will be measured at Baseline (7 or 14 days before the intervention), Intervention (immediately after the intervention), post-intervention (7 days after the intervention) and Follow-up (28 days after the intervention)

Change from baseline in the Obsessive-Compulsive Inventory Revised (OCI-R)

Timeframe: Will be measured at Baseline (7 or 14 days before the intervention), Intervention (immediately after the intervention), post-intervention (7 days after the intervention) and Follow-up (28 days after the intervention)

Change from baseline in the Generalized Anxiety Scale-7 (GAD-7)

Timeframe: Will be measured at Baseline (7 or 14 days before the intervention), Intervention (immediately after the intervention), post-intervention (7 days after the intervention) and Follow-up (28 days after the intervention)

Change from baseline in The Overall Anxiety Severity and Impairment Scale (OASIS)

Timeframe: Will be measured at Baseline (7 or 14 days before the intervention), Intervention (immediately after the intervention), post-intervention (7 days after the intervention) and Follow-up (28 days after the intervention)

Trial details

NCT IDNCT05292807

SponsorHebrew University of Jerusalem

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01

Contact for this trial

Snir Barzilay, PhD. student

+972 50 4499 435 snir.barzilay@mail.huji.ac.il

View on ClinicalTrials.gov More Social Anxiety trials